Alaunos Therapeutics | ZIOP - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Alaunos Therapeutics USD 1.94M 941K 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Baxter International USD 1.97B 240M 2025-12
Biogen USD 3.38B 374.2M 2026-03
Bioline Rx USD 7.91M 725K 2025-09
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Celltrion KRW 29.65B 799.42B 2025-06
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Curis USD 10.14M 10.14M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Incyte USD 4.02B 435.22M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
J&J USD 21.69B 1.98B 2026-03
Kangmei Pharma CNY 1.18B 278M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Merck USD 14.57B 3.6B 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Novartis USD 11.44B 1.88B 2025-12
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pfizer USD 1.34B 295M 2025-09
Pharma Mar EUR 17.82M 3.78M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Qiagen NV USD 839M 516.58M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
TG Therapeutics USD 199.51M 21.2M 2025-12
Tilray USD 264.83M 43.16M 2025-06
Verastem USD 204.99M 67.28M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06